Assessing the clinical application of the PANOMEN 3 classification in a large cohort of pituitary tumors
In the postoperative setting, PANOMEN 3 classification is useful in prediction of recurrence and need for further therapy. However, it was a weaker tool for predicting recurrence than the French classification.
Authors
- Mark McLean (ORCID: https://orcid.org/0000-0001-8028-3108)
- Prishila Fookeerah (ORCID: https://orcid.org/0000-0001-9314-9733)
- Meena Shingde (ORCID: https://orcid.org/0009-0007-3919-9853)
- Winny Varikatt
- Ann McCormack (ORCID: https://orcid.org/0000-0002-2859-5566)
- Mark Dexter
- Sue Lynn Lau (ORCID: https://orcid.org/0009-0009-5349-8766)
Institutions
- The University of Sydney (AU)
- Garvan Institute of Medical Research (AU)
- Westmead Hospital (AU)
- UNSW Sydney (AU)
- St Vincent's Hospital Sydney (AU)
- St Vincent's Clinic (AU)
- Westmead Institute (AU)
- Western Sydney University (AU)
Publication Details
- Journal
- European Journal of Endocrinology
- Published
- 2025-06-27
- DOI
- https://doi.org/10.1093/ejendo/lvaf122
- Citations
- 6
- Primary Topic
- Pituitary Gland Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 7.77